A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pharmaceutics
Prif Awduron: Chirio, Daniela, Peira, Elena, Sapino, Simona, Chindamo, Giulia, Oliaro-Bosso, Simonetta, Adinolfi, Salvatore, Dianzani, Chiara, Baratta, Francesca, Gallarate, Marina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071554/
https://ncbi.nlm.nih.gov/pubmed/33921167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13040560
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg